गाइड से जुड़ी प्रश्नोत्तरी · मध्यम स्तर

AI Diabetic Retinopathy Screening Quiz

Tests device-specific authorization, image-quality failure, referral pathways, screening limits, and the continuing role of comprehensive eye exams.

प्रश्न 1 का 8

Under IDx-DR's FDA-authorized intended use, which patient and imaging scope is specified?

प्रत्येक प्रश्न का पूर्वावलोकन करें8 प्रश्न

जैसे ही आप प्रश्नोत्तरी लेते हैं उत्तर और स्पष्टीकरण दिखाई देते हैं।

  1. Under IDx-DR's FDA-authorized intended use, which patient and imaging scope is specified?
    • Adults with diabetes and no prior diabetic-retinopathy diagnosis, imaged with the specified Topcon NW400 to detect more-than-mild retinopathy
    • Any age with diabetes, using any fundus camera to detect all stages of retinopathy
    • Adults already diagnosed with retinopathy, using the NW400 to determine treatment response
    • Adults without diabetes, using smartphone photos to screen for glaucoma and retinopathy
  2. What does FDA authorization for IDx-DR apply to?
    • Every AI application that analyzes eye photographs
    • Any camera and patient population without validation
    • Treatment of diabetic retinopathy
    • A specific device, intended use, image workflow, and labeling
  3. How should a positive screening result be handled under IDx-DR labeling?
    • Skip follow-up if the patient has no symptoms
    • Refer the patient to an eye-care provider for further evaluation and care
    • Treat the disease automatically from the AI result
    • Assume the patient has glaucoma
  4. What does a no-result or poor-quality image mean?
    • It confirms that the retina is normal
    • It should be discarded without further action
    • The screening was not completed and retest or referral is needed per labeling
    • It is equivalent to a negative screen
  5. Which claim about IDx-DR would be unsupported by its FDA-labeled intended use?
    • It is intended for eligible adults with diabetes and no prior diabetic-retinopathy diagnosis
    • It screens retinal images for more-than-mild diabetic retinopathy
    • It uses retinal images captured with the specified Topcon NW400 camera
    • It also screens for glaucoma
  6. Does a negative AI screen replace regular eye-care recommendations?
    • Yes, it screens for every eye disease
    • No, but only if the camera is not connected to Wi-Fi
    • No; people with diabetes should continue appropriate comprehensive eye exams
    • Yes, it guarantees future eye health
  7. Why are image-quality checks part of the screening workflow?
    • The algorithm needs suitable retinal photographs to generate a usable result
    • They allow the device to diagnose diabetes
    • They replace referral for a positive screen
    • They make every camera compatible automatically
  8. What should a clinic measure after adopting an AI eye-screening device?
    • The number of AI terms in a patient leaflet
    • Ungradable images, referral completion, and performance in the intended population
    • Only the number of images uploaded
    • Only the device’s purchase price